ICB 10 international classification of diseases of go. ICD - what is it? Explanation of the abbreviation

List of ICD-10 classes

ICD-10 - International classification of diseases of the 10th revision. As of January 2007, is the generally accepted classification for coding medical diagnoses, developed by the World Health Organization. ICD-10 consists of 21 sections, each of which contains subsections with codes of diseases and conditions.

Wikimedia Foundation. 2010.

• Primitivism
• Rocks Universal

See what the "List of ICD-10 classes" is in other dictionaries:

List of ICD-9 codes - This article should be wikified. Please fill it out according to the rules of article formatting. Transition table: from ICD 9 (chapter V, Mental disorders) to ICD 10 (section V, Mental disorders) (adapted Russian version) ... ... Wikipedia

List of medical abbreviations - This page is a glossary. # A ... Wikipedia

ICD - 10. Cover of the official publication (published in "Medicine" on behalf of the Ministry of Health of the Russian Federation). International Statistical Classification of Diseases and Related Health Problems (ICD 10 International Statistical Classification of Diseases and Related ... ... Wikipedia

ICD-10 - ICD 10. Cover of the official publication (published in "Medicine" on behalf of the Ministry of Health of the Russian Federation). International Statistical Classification of Diseases and ... ... Wikipedia

It was created to unify the process of coding diseases and pathological conditions. As a result, doctors from all over the world are now able to exchange information without even knowing a large number of languages.

History of creation of ICD

ICD is a classification, the basis of which was laid back in 1893 by Jacques Bertillon, who at that time was head of the Bureau of Statistics in Paris. On behalf of the International Statistical Institute, he developed a classification of causes of death. In his work, he started from earlier Swiss, French and English works.

Jacques Bertillon's classification of causes of death was generally accepted and used extensively in Europe and North America. During the 6th revision in 1948, its structure also included diseases and pathological conditions that do not lead to death.

The modern ICD is a document of the 10th revision approved by the World Health Assembly in 1990.In fact, practicing doctors began to use it in 1994. On the territory of the Russian Federation, the official use of ICD-10 began only in 1997

Since 2012, scientists have been developing ICD-11, but to date this document has not come into force.

Features of the structure and basic principles of ICD-10

The 10th version of the international classification of diseases introduced fundamental changes to its structure, the main of which was the use of an alphanumeric coding system.

The ICD-10 classification has 22 classes, which are collected in the following groups:

• epidemic diseases;
• general or constitutional diseases;
• local diseases that are grouped according to anatomical characteristics;
• developmental diseases;
• traumatic injury.

Some classes include several letter headings at once. The 11th revision of this document is currently underway, but no significant changes to the structure of the classification are planned.

ICD composition

This international classification consists of three volumes at once:

• the first volume includes a basic classification, special lists for summary statistical developments, a section on "Morphology of neoplasms", as well as nomenclature rules;
• the second volume contains clear instructions on how to use the ICD-10 correctly;
• the third volume includes an alphabetical index attached to the main classification.

Today, these 3 volumes are most often combined and released under 1 cover for the convenience of the user.

Letter headings

ICD-10 is an international classification of diseases, and therefore its creators had to think over unified designations that are understandable to every specialist. For this, it was decided to use the headings designated in Latin letters. There are 26 of them in total. The creators left the U heading for the further development of ICD-10.

The disease codes in this document, in addition to the letter designation, also include a number. It can be two or three digits. Thanks to this, the creators of the ICD managed to encode all known diseases.

Practical use of ICD-10

Deciphering this coding system with the help of an appropriate reference book is absolutely no difficulty, not only for specialist doctors, but also for people who do not have any medical knowledge. Doctors use ICD on an ongoing basis. Any disease that occurs in their patients is coded according to the international classification. Most often, in practice, doctors use them for:

1. Issuance of medical documents, if necessary, conceal the diagnosis (usually when a person goes through a commission for getting a job, receives a document confirming that the patient really was at a doctor's appointment).
2. Filling out medical documentation (extract from the medical history, inpatient card).
3. Filling in statistical reporting documents.

As a result, ICD-10 allows not only the exchange of information between doctors of different countries, but also the maintenance of medical secrecy.

Coding by class

ICD-10 consists of 22 classes. Each of them includes diseases that have general principles of pathogenesis or that relate to a specific anatomical region. All classes have their own designation in the form of Latin numbers. Among them:

As for the 22nd class, it is reserved for that group of diseases or pathological conditions, which is currently not yet established.

Further development paths

ICD-10 is an international classification of diseases that has serious opportunities for development. Currently, doctors use this document not only in paper form, but also in electronic form. For these purposes, a huge number of thematic sites have been created, and several mobile applications have been developed.

Also, ICD-10 coding is embedded in all electronic systems of medical integration, which are currently very actively developing in the countries of the post-Soviet space. Taking into account the presence of a free heading U, this classification is able to include in the future a whole class of new diseases. Moreover, now it is already sometimes used by scientists to assign a time code to those diseases and pathological conditions, the cause of which has not yet been fully understood. Distribution into a permanent rubric further occurs after clarification of the main points of the etiology and pathogenesis of the disease. As a result, the ICD is an international classification of diseases, which has every opportunity for further development.

In Russia, the study of the morbidity structure began with the period of zemstvo medicine, and the first classification of diseases appeared already in 1876. At the VII Pirogov Congress of Physicians, the first domestic nomenclature of diseases was adopted. At the beginning of the 20th century, the International Classification of Diseases was created, and at present its 10th revision is in force in all countries of the world. ICD-10 was adopted by the 43rd World Health Assembly in Geneva (1989) and has been recommended for use in the Russian Federation since 1993.
The main innovation in ICD-10 compared to ICD-9 is the use of an alphanumeric coding system with four-digit headings, including one letter of the Latin alphabet, followed by three numbers (for example, A00.0-A99.9). Such a system makes it possible to more than double the amount of coded information. The introduction of letters into the headings made it possible to encode up to 100 three-digit categories in each class. Some three-digit headings were left free, which will allow them to be expanded and revised in the future. The number of such free headings varies from class to class.
ICD-10 includes 21 classes of diseases and 4 additional sections.

CLASS IX. Diseases of the circulatory system (I00-I99)

This class contains the following blocks:
I00-I02 Acute rheumatic fever
I05-I09 Chronic rheumatic heart disease
I10-I15 Diseases characterized by high blood pressure
I20-I25 Cardiac ischemia
I26-I28 Cor pulmonale and pulmonary circulation disorders
I30-I52 Other heart diseases
I60-I69 Cerebrovascular disease
I70-I79 Diseases of the arteries, arterioles and capillaries
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
I95-I99 Other and unspecified diseases of the circulatory system

The following categories are marked with an asterisk:
I32* Pericarditis in diseases classified elsewhere
I39* Endocarditis and valvular disease in diseases classified elsewhere
I41* Myocarditis in diseases classified elsewhere
I43* Cardiomyopathies in diseases classified elsewhere
I52* Other lesions of the heart in diseases classified elsewhere
I68* Disorders of cerebral vessels in diseases classified elsewhere
I79* Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
I98* Other disorders of the circulatory system in diseases classified elsewhere

ACUTE RHEUMATIC FEVER (I00-I02)

I00 Rheumatic fever without mention of cardiac involvement

Acute or subacute rheumatic arthritis

I01 Rheumatic fever with cardiac involvement

Excludes: chronic heart disease of rheumatic origin ( I05-I09) without the simultaneous development of an acute rheumatic process or without the phenomena of activation or recurrence of this process If there is any doubt about the activity of the rheumatic process at the time of death, one should refer to the recommendations and rules for coding mortality set out in t2.

I01.0 Acute rheumatic pericarditis
I00combined with pericarditis
Excludes: pericarditis, not designated as rheumatic ( I30. -)
I01.1 Acute rheumatic endocarditis
Any condition related to a rubric I00, in combination with endocarditis or valvulitis
Acute rheumatic valvulitis
I01.2 Acute rheumatic myocarditis
Any condition related to a rubric I00, combined with myocarditis
I01.8 Other acute rheumatic heart diseases
Any condition related to a rubric I00, in combination with other or multiple forms of conditions
with the involvement of the heart. Acute rheumatic pancarditis
I01.9 Acute rheumatic heart disease, unspecified
Any condition related to a rubric I00, in combination with an unspecified form of heart disease
rheumatic carditis, acute
heart disease, active or acute

I02 Rheumatic chorea

Includes: Sydenham's chorea
Excludes: chorea:
NOS ( G25.5)
Huntington ( G10)
I02.0 Rheumatic chorea with cardiac involvement
Chorea NOS with cardiac involvement. Rheumatic chorea with involvement of the heart of any of the indicated in the heading I01... - type
I02.9 Rheumatic chorea without cardiac involvement. Rheumatic chorea NOS

CHRONIC RHEUMATIC HEART DISEASES (I05-I09)

I05 Rheumatic diseases of the mitral valve

Includes: conditions classified into headings I05.0
and I05.2-I05.9, specified or not specified as rheumatic
I34. -)

I05.0 Mitral stenosis. Narrowing of the mitral valve (rheumatic)
I05.1 Rheumatic mitral insufficiency
Rheumatic mitral:
functional impairment
regurgitation
I05.2 Mitral stenosis with insufficiency. Mitral stenosis with functional impairment or regurgitation
I05.8 Other diseases of the mitral valve. Mitral (valve) not enough
I05.9 Unspecified mitral valve disease. Mitral (valvular) disorder (chronic) NOS

I06 Rheumatic diseases of the aortic valve

Excluded: cases not I35. -)

I06.0 Rheumatic aortic stenosis. Rheumatic narrowing of the aortic valve
I06.1 Rheumatic aortic valve insufficiency
Rheumatic aortic:
failure
regurgitation
I06.2 Rheumatic aortic stenosis with insufficiency
Rheumatic aortic stenosis with functional impairment or regurgitation
I06.8 Other rheumatic aortic valve diseases
I06.9 Unspecified rheumatic aortic valve disease. Rheumatic aortic (valve) disease NOS

I07 Rheumatic diseases of the tricuspid valve

Included: cases, specified or not specified as
rheumatic
Excluded: cases specified as non-rheumatic ( I36. -)

I07.0 Tricuspid stenosis. Tricuspid (valve) stenosis (rheumatic)
I07.1 Tricuspid insufficiency. Tricuspid (valve) insufficiency (rheumatic)
I07.2 Tricuspid stenosis with insufficiency
I07.8 Other diseases of the tricuspid valve
I07.9 Unspecified tricuspid valve disease. Dysfunction of the NOS tricuspid valve

I08 Lesions of several valves

Includes: cases, specified or not specified as rheumatic
Excluded: endocarditis, valve not specified ( I38)
rheumatic endocardial disease, valve
not specified ( I09.1)

I08.0 Combined mitral and aortic valve lesions
Defeat of both mitral and aortic valves, specified or not specified as rheumatic
I08.1 Associated lesions of the mitral and tricuspid valves
I08.2 Associated lesions of the aortic and tricuspid valves
I08.3 Combined mitral, aortic, and tricuspid valve lesions
I08.8 Other multiple valve diseases
I08.9 Multiple valvular disease, unspecified

I09 Other rheumatic heart diseases

I09.0 Rheumatic myocarditis
Excludes: myocarditis, not specified as rheumatic ( I51.4)
I09.1 Rheumatic diseases of the endocardium, the valve is not specified
Rheumatic:
endocarditis (chronic)
valvulitis (chronic)
Excludes: endocarditis, valve not specified ( I38)
I09.2 Chronic rheumatic pericarditis
Adhesive pericarditis, rheumatic
Chronic rheumatic:
mediastinopericarditis
myopericarditis
Excluded: conditions not specified as rheumatic ( I31. -)
I09.8 Other specified rheumatic heart diseases. Rheumatic pulmonary valve disease
I09.9 Rheumatic heart disease, unspecified
Rheumatic (th):
carditis
heart failure
Excludes: rheumatoid carditis ( M05.3)

DISEASES CHARACTERIZED BY INCREASED BLOOD PRESSURE (I10-I15)

Excludes: complicating pregnancy, childbirth or the postpartum period ( O10 -O11 , O13 -O16 )
with the involvement of coronary vessels ( I20-I25)
neonatal hypertension ( P29.2)
pulmonary hypertension ( I27.0)

I10 Essential [primary] hypertension

High blood pressure
Hypertension (arterial) (benign) (essential)
(malignant) (primary) (systemic)
brain ( I60 -I69 )
eyes ( H35.0 )

I11 Hypertensive heart disease [hypertensive heart disease with predominant heart disease]

I50. — , I51.4-I51.9due to hypertension

I11.0 Hypertensive [hypertensive] disease with predominant heart disease with (congestive) cardiac
failure. Hypertensive [hypertensive] heart failure
I11.9 Hypertensive [hypertensive] disease with predominant heart disease without (congestive) cardiac
failure. Hypertensive heart disease NOS

I12 Hypertensive [hypertensive] disease with predominant kidney damage

Included: any state listed under headings N18. — , N19... or N26... - in combination with any condition,
listed in the heading I10
renal arteriosclerosis
arteriosclerotic nephritis (chronic)
(interstitial)
hypertensive nephropathy
nephrosclerosis
Excludes: secondary hypertension ( I15. -)

I12.0
Hypertensive renal failure
I12.9 Hypertensive [hypertensive] disease with predominantly renal impairment without renal failure
Renal hypertension NOS

I13 Hypertensive [hypertensive] disease with predominant damage to the heart and kidneys

Included: any condition specified in the heading I11... -, in combination with any condition indicated in the heading I12... disease:
cardio-renal
cardiovascular renal

I13.0
insufficiency
I13.1 Hypertensive [hypertensive] disease with predominantly renal impairment with renal failure
I13.2 Hypertensive [hypertensive] disease with predominant heart and kidney damage with (congestive) cardiac
failure and renal failure
I13.9 Unspecified hypertensive [hypertensive] disease with predominant heart and kidney involvement

I15 Secondary hypertension

Excludes: involving vessels:
brain ( I60 -I69 )
eyes ( H35.0 )

I15.0 Renovascular hypertension
I15.1 Hypertension secondary to other renal lesions
I15.2 Hypertension secondary to endocrine disorders
I15.8 Other secondary hypertension
I15.9 Secondary hypertension, unspecified

CORONARY HEART DISEASE (I20-I25)

Note For morbidity statistics, the definition of "duration" used in the I21-I25, includes the time interval from the onset of an ischemic attack to the patient's admission to a medical institution.
For mortality statistics, it covers the time span from the onset of an ischemic attack to the onset of death.

Included: with mention of hypertension ( I10-I15)

I20 Angina [angina pectoris]

I20.0 Unstable angina
Angina pectoris:
growing
stress, first appeared
stress progressive
Intermediate coronary syndrome
I20.1 Angina pectoris with documented spasm
Angina pectoris:
angiospastic
Prinzmetal
spasmodic
variant
I20.8 Other forms of angina pectoris. Exertional angina
I20.9 Unspecified angina
Angina pectoris:
NOS
cаrdiаc
Angina syndrome. Ischemic chest pain

I21 Acute myocardial infarction

Included: myocardial infarction, specified as acute or for an established duration of 4 weeks (28 days) or less
from start
Excluded: some current complications after acute myocardial infarction ( I23. -)
myocardial infarction:
carried over in the past ( I25.2)
specified as chronic or duration
more than 4 weeks (more than 28 days) from the beginning ( I25.8)
subsequent ( I22. -)
postinfarction myocardial syndrome ( I24.1)

I21.0 Acute transmural myocardial anterior wall infarction
front (wall) NOS
anterior apical
anterolateral
anteroseptal
I21.1 Acute transmural infarction of the lower myocardial wall
Transmural myocardial infarction (acute):
diaphragmatic wall
bottom (wall) NOS
inferolateral
inferior
I21.2 Acute transmural myocardial infarction of other specified localizations
Transmural infarction (acute):
apical-lateral
basal-literal
upper lateral
side (wall) NOS
posterior (true)
posterobasal
posterolateral
posterseptal
partition NOS
I21.3 Acute transmural myocardial infarction of unspecified localization. Transmural myocardial infarction NOS
I21.4 Acute subendocardial myocardial infarction. Non-transmural myocardial infarction NOS
I21.9 Acute myocardial infarction, unspecified. Myocardial infarction (acute) NOS

I22 Recurrent myocardial infarction

Includes: recurrent myocardial infarction
Excludes: myocardial infarction, specified as chronic or
with an established duration of more than 4 weeks
(more than 28 days) from the beginning ( I25.8)

I22.0 Recurrent anterior myocardial infarction
Re-infarction (acute):
front (wall) NOS
anterior apical
anterolateral
anteroseptal
I22.1 Recurrent infarction of the lower myocardial wall
Re-infarction (acute):
diaphragmatic wall
bottom (wall) NOS
inferolateral
inferior
I22.8 Recurrent myocardial infarction of another specified localization
Recurrent myocardial infarction (acute):
apical-lateral
basal-literal
upper lateral
side (wall) NOS
posterior (true)
posterobasal
posterolateral
posterseptal
partition NOS
I22.9 Recurrent myocardial infarction of unspecified site

I23 Certain current complications of acute myocardial infarction

Excluded: the listed conditions:
accompanying acute myocardial infarction ( I21-I22)
not specified as current complications of acute
myocardial infarction ( I31 . — , I51 . -)

I23.0 Hemopericardium as the nearest complication of acute myocardial infarction
I23.1 Atrial septal defect as a current complication of acute myocardial infarction
I23.2 Ventricular septal defect as a current complication of acute myocardial infarction
I23.3 Heart wall rupture without hemopericardium as a current complication of acute myocardial infarction
Excluded: with hemopericardium ( I23.0)
I23.4 Tendon cord rupture as a current complication of acute myocardial infarction
I23.5 Rupture of the papillary muscle as a current complication of acute myocardial infarction
I23.6 Atrial thrombosis, atrial appendage and ventricle as a current complication of acute myocardial infarction
I23.8 Other current complications of acute myocardial infarction

I24 Other forms of acute ischemic heart disease

Excluded: angina pectoris ( I20. -)
transient myocardial ischemia of the newborn ( P29.4)

I24.0 Coronary thrombosis that does not lead to myocardial infarction
Coronary (arteries) (veins):
embolism) not leading
occlusion) to heart attack
thromboembolism) myocardium
Excluded: chronic coronary thrombosis or with an established duration of more than 4 weeks (more
28 days) from start ( I25.8)
I24.1 Dressler's syndrome. Postinfarction syndrome
I24.8 Other forms of acute coronary artery disease
Coronary:
failure
inferiority
I24.9 Acute ischemic heart disease, unspecified
Excludes: ischemic heart disease (chronic) NOS ( I25.9)

I25 Chronic ischemic heart disease

Excludes: cardiovascular disease NOS ( I51.6)

I25.0 Atherosclerotic cardiovascular disease, so described
I25.1 Atherosclerotic heart disease
Coronary (artery):
atheroma
atherosclerosis
disease
sclerosis
I25.2 Past myocardial infarction. Healed myocardial infarction
Previous myocardial infarction diagnosed with an ECG or other special study with
currently no symptoms
I25.3 Heart aneurysm
Aneurysm:
walls
ventricular
I25.4 Coronary artery aneurysm. Acquired coronary arteriovenous fistula
Excludes: congenital coronary (artery) aneurysm ( Q24.5)
I25.5 Ischemic cardiomyopathy
I25.6 Asymptomatic myocardial ischemia
I25.8 Other forms of chronic ischemic heart disease
Any condition indicated in the rubrics I21-I22 and I24... - designated as chronic or for an established duration of more than 4 weeks (more than 28 days) from the beginning
I25.9 Chronic ischemic heart disease, unspecified. Coronary artery disease (chronic) NOS

PULMONARY HEART AND PULMONARY BLOOD CIRCULATION DISORDERS (I26-I28)

I26 Pulmonary embolism

Includes: pulmonary (arteries) (veins):
heart attack
thromboembolism
thrombosis
Excluded: complicating:
abortion ( O03-O07), ectopic or molar
pregnancy ( O00-O07, O08.2)
O88. -)

I26.0 Pulmonary embolism with mention of acute cor pulmonale. Acute cor pulmonale NOS
I26.9 Pulmonary embolism without mention of acute cor pulmonale. Pulmonary embolism NOS

I27 Other forms of pulmonary heart failure

I27.0 Primary pulmonary hypertension
Pulmonary (arterial) hypertension (idiopathic) (primary)
I27.1 Kyphoscoliotic heart disease
I27.8 Other specified forms of pulmonary heart disease
I27.9 Pulmonary heart failure, unspecified
Chronic heart disease of pulmonary origin. Pulmonary heart (chronic) NOS

I28 Other diseases of pulmonary vessels

I28.0 Arteriovenous fistula of the pulmonary vessels
I28.1 Pulmonary aneurysm
I28.8 Other specified pulmonary vascular diseases
Gap)
Stenosis) of the pulmonary vessel
Stricture)
I28.9 Unspecified pulmonary vascular disease

OTHER HEART DISEASES (I30-I52)

I30 Acute pericarditis

Includes: acute pericardial effusion
Excludes: rheumatic pericarditis (acute) ( I01.0)

I30.0 Acute non-specific idiopathic pericarditis
I30.1 Infectious pericarditis
Pericarditis:
pneumococcal
purulent
staphylococcal
streptococcal
viral
Pyopericarditis
B95-B97).
I30.8 Other forms of acute pericarditis
I30.9 Acute pericarditis, unspecified

I31 Other diseases of the pericardium

Excluded: some current complications of acute heart attack
myocardium ( I23. -)
postcardiac syndrome ( I97.0)
heart injury ( S26 . -)
diseases specified as rheumatic ( I09.2)

I31.0 Chronic adhesive pericarditis. Accretio cordis. Adhesive pericardium. Adhesive mediastinopericarditis
I31.1 Chronic constrictive pericarditis. Concretio cordis. Pericardial calcification
I31.2 Hemopericardium, not elsewhere classified
I31.3 Pericardial effusion (non-inflammatory) Chylopericardium
I31.8 Other specified diseases of the pericardium. Epicardial plaques. Focal pericardial adhesions
I31.9 Diseases of the pericardium, unspecified. Cardiac tamponade. Pericarditis (chronic) NOS

I32 * Pericarditis in diseases classified elsewhere

I33 Acute and subacute endocarditis

Excludes: acute rheumatic endocarditis ( I01.1)
endocarditis NOS ( I38)

I33.0 Acute and subacute infective endocarditis
Endocarditis (acute) (subacute):
bacterial
infectious NOS
slow flowing
malignant
septic
ulcerative
If it is necessary to identify the infectious agent, use an additional code ( B95-B97).
I33.9 Acute endocarditis, unspecified
Endocarditis)
Myoendocarditis) acute or subacute
Perirendocarditis)

I34 Non-rheumatic mitral valve disorders

Excluded: mitral (valve):
disease ( I05.9)
failure ( I05.8)
stenosis ( I05.0)
for an unknown reason, but with a mention of it
aortic valve disease ( I08.0)
mitral stenosis or obstruction ( I05.0)
I05. -)

I34.0 Mitral (valve) insufficiency
Mitral (valve):


regurgitation)
I34.1 Mitral valve prolapse [prolapse]. Bulging mitral valve syndrome
Excluded: Marfan syndrome ( Q87.4)
I34.2 Non-rheumatic mitral stenosis
I34.8 Other non-rheumatic mitral valve disorders
I34.9 Unspecified non-rheumatic mitral valve disorder

I35 Non-rheumatic aortic valve lesions

Excluded: hypertrophic subaortic stenosis ( I42.1)
for an unknown reason, but mentioning
about mitral valve disease ( I08.0)
lesions specified as rheumatic ( I06. -)

I35.0 Aortic (valve) stenosis
I35.1 Aortic (valve) insufficiency
Aortic (valve):
functional) NOS or specified reason,
failure) other than rheumatic
regurgitation)
I35.2 Aortic (valve) stenosis with insufficiency
I35.8 Other lesions of the aortic valve
I35.9 Unspecified aortic valve disorder

I36 Non-rheumatic tricuspid valve lesions

Excluded: without specifying the reason ( I07. -)
specified as rheumatic ( I07. -)

I36.0 Non-rheumatic tricuspid stenosis
I36.1 Non-rheumatic tricuspid valve insufficiency
Tricuspid (valve):
functional) NOS or specified reason,
failure) other than rheumatic
regurgitation)
I36.2 Non-rheumatic tricuspid stenosis with insufficiency
I36.8 Other non-rheumatic tricuspid valve lesions
I36.9 Unspecified non-rheumatic tricuspid valve disorder

I37 Disorders of the pulmonary valve

Excluded: disorders specified as rheumatic ( I09.8)

I37.0 Pulmonary valve stenosis
I37.1 Pulmonary valve insufficiency
Pulmonary valve:
functional) NOS or specified reason,
failure) other than rheumatic
regurgitation)
I37.2 Pulmonary valve stenosis with insufficiency
I37.8 Other lesions of the pulmonary valve
I37.9 Unspecified pulmonary valve disorder

I38 Endocarditis, valve not specified

Endocarditis (chronic) NOS
Valvetrain (s):
inferiority)
insufficiency) unspecified- (NOS or specified
regurgitation) not (causes other than
stenosis) valve (rheumatic
Vulvitis (chronic))
Excluded: endocardial fibroelastosis ( I42.4)
cases specified as rheumatic ( I09.1)

I39 * Endocarditis and valvular disease in diseases classified elsewhere

Included: endocardial damage in:
candidal infection ( B37.6+)
gonococcal infection ( A54.8+)
liebman-Sachs disease ( M32.1+)
meningococcal infection ( A39.5+)
rheumatoid arthritis ( M05.3+)
syphilis ( A52.0+)

tuberculosis ( A18.8+)

• typhoid fever ( A01.0+)

I39.0* Disorders of the mitral valve in diseases classified elsewhere
I39.1* Disorders of the aortic valve in diseases classified elsewhere
I39.2* Lesions of the tricuspid valve in diseases classified elsewhere
I39.3* Disorders of the pulmonary valve in diseases classified elsewhere
I39.4* Multiple valvular lesions in diseases classified elsewhere

I39.8* Endocarditis, valve not specified, in diseases classified elsewhere

I40 Acute myocarditis

I40.0 Infectious myocarditis. Septic myocarditis
If it is necessary to identify the infectious agent, use an additional code ( B95-B97).
I40.1 Isolated myocarditis
I40.8 Other types of acute myocarditis
I40.9 Acute myocarditis, unspecified

I41 * Myocarditis in diseases classified elsewhere

I42 Cardiomyopathy

Excluded: cardiomyopathy complicating:
pregnancy ( O99.4)
postpartum period ( O90.3)
ischemic cardiomyopathy ( I25.5)

I42.0 Dilated cardiomyopathy
I42.1 Obstructive hypertrophic cardiomyopathy. Hypertrophic subaortic stenosis
I42.2 Another hypertrophic cardiomyopathy. Non-obstructive hypertrophic cardiomyopathy
I42.3 Endomyocardial (eosinophilic) disease
Endomyocardial (tropical) fibrosis. Leffler's endocarditis
I42.4 Endocardial fibroelastosis. Congenital cardiomyopathy
I42.5 Other restrictive cardiomyopathy
I42.6 Alcoholic cardiomyopathy
I42.7 Cardiomyopathy due to drugs and other external factors
If it is necessary to identify the cause, use an additional external cause code (class XX).
I42.8 Other cardiomyopathies
I42.9 Unspecified cardiomyopathy. Cardiomyopathy (primary) (secondary) NOS

I43 * Cardiomyopathy in diseases classified elsewhere

I44 Atrioventricular [atrioventricular] and left bundle branch block [His]

I44.0 First degree atrioventricular block
I44.1 Second-degree atrioventricular block
Atrioventricular block, type I and II. Mobitz blockade, types I and II. Blockade of the second degree, types I and II
Blockade of Wenckebach
I44.2 Complete atrioventricular block. Complete heart block NOS. Blockade of the third degree
I44.3 Other and unspecified atrioventricular block. Atrioventricular block NOS
I44.4 Blockade of the anterior branch of the left bundle branch
I44.5 Posterior branch block of the left bundle branch
I44.6 Other and unspecified bundle block. Hemiblockade of the left bundle branch NOS
I44.7 Left bundle-branch block, unspecified

I45 Other conduction disorders

I45.0 Right bundle branch block
I45.1 Other and unspecified right bundle-branch block. Right bundle branch block NOS
I45.2 Two-beam blockade
I45.3 Three-beam blockade
I45.4 Non-specific intraventricular block. Beam pedicle block NOS
I45.5 Other specified heart block
Sinus-atrial block. Sinoauricular block
Excludes: heart block NOS ( I45.9)
I45.6 Premature excitement syndrome. Anomalies of atrioventricular excitation
Atrioventricular conduction:
accelerated
along additional paths
with premature excitement
Laun-Ganong-Levin syndrome
Wolff-Parkinson-White syndrome
I45.8 Other specified conduction disorders. Atrioventricular dissociation. Interferential dissociation
I45.9 Conduction disorder, unspecified. Heart block NOS. Stokes-Adams Syndrome

I46 Cardiac arrest

Excluded: cardiogenic shock ( R57.0)
complicating:
O00 -O07 , O08.8 )
O75.4)

I46.0 Cardiac arrest with successful cardiac recovery
I46.1 Sudden cardiac death, as described
Excluded: sudden death:
NOS ( R96. -)
at:
violation of conductivity ( I44-I45)
myocardial infarction ( I21 -I22 )
I46.9 Cardiac arrest, unspecified

I47 Paroxysmal tachycardia

Excluded: complicating:
abortion, ectopic or molar pregnancy ( O00 -O07 , O08.8 )
obstetric surgery
and procedures ( O75.4)
tachycardia NOS ( R00.0)

I47.0 Recurrent ventricular arrhythmia
I47.1 Supraventricular tachycardia
Paroxysmal tachycardia:
atrial
atrioventricular
outgoing connection
nodal
I47.2 Ventricular tachycardia
I47.9 Paroxysmal tachycardia, unspecified. Bouveret - (Hoffman) syndrome

I48 Atrial fibrillation and flutter

I49 Other disorders of heart rhythm

Excluded: bradycardia NOS ( R00.1)
conditions complicating:
abortion, ectopic or molar pregnancy ( O00 -O07 , O08.8 )
obstetric surgery and procedures ( O75.4)
heart rhythm disturbance in a newborn ( P29.1)

I49.0 Ventricular fibrillation and flutter
I49.1 Premature depolarization of the atria. Premature atrial contractions
I49.2 Premature depolarization emanating from the compound
I49.3 Premature ventricular depolarization
I49.4 Other and unspecified premature depolarization
Ectopic systoles. Extrasystoles. Extrasystolic arrhythmia
Premature:
reductions NOS
compression
I49.5 Sick sinus syndrome. Tachycardia-bradycardia syndrome
I49.8 Other specified cardiac arrhythmias
Rhythm disturbance:
coronary sinus
ectopic
nodal
I49.9 Unspecified heart rhythm disorder. Arrhythmia (cardiac) NOS

I50 Heart failure

Excluded: conditions complicating:

• abortion, ectopic or molar pregnancy ( O00 -O07 , O08.8 )
• obstetric surgery and procedures ( O75.4)
• conditions caused by hypertension ( I11.0)
• kidney disease ( I13. -)
• consequences of heart surgery or in the presence of a heart prosthesis ( I97.1)
• heart failure in a newborn ( P29.0)

I50.0 Congestive heart failure. Congestive heart disease
Right ventricular failure (secondary to left ventricular heart failure)
I50.1 Left ventricular failure
Acute pulmonary edema) with mention of heart disease
Acute pulmonary edema) NOS or heart failure
Cardiac asthma
Left sided heart failure
I50.9 Heart failure, unspecified. Insufficiency of both ventricles
Cardiac (cardiac) or myocardial insufficiency NOS

I51 Complications and ill-defined heart diseases

Excluded:

• any conditions indicated in the headings I51.4-I51.9,
• due to hypertension ( I11. -)
• with kidney disease ( I13. -)
• complications accompanying an acute heart attack ( I23. -)
• specified as rheumatic ( I00-I09)

I51.0 Acquired septal defect
Acquired septal defect (long-standing):
atrial
atrial appendage
ventricular
I51.1 Tendon rupture of notochord, not elsewhere classified
I51.2 Ruptured papillary muscle, not elsewhere classified
I51.3 Intracardiac thrombosis, not elsewhere classified
Thrombosis (long-standing):
apical
atrial
atrial appendage
ventricular
I51.4 Myocarditis, unspecified. Myocardial fibrosis
Myocarditis:
NOS
chronic (interstitial)

I51.5 Myocardial degeneration
Degeneration of the heart or myocardium:
fatty
senile
Myocardial disease
I51.6 Cardiovascular disease, unspecified
Cardiovascular attack NOS
Excludes: atherosclerotic cardiovascular disease, as described ( I25.0)
I51.7 Cardiomegaly
Heart (s):
expansion
hypertrophy
Dilation of the ventricles
I51.8 Other ill-defined heart diseases
Carditis (acute) (chronic). Pancarditis (acute) (chronic)
I51.9 Unspecified heart disease

I52 * Other cardiac disorders in diseases classified elsewhere

CEREBROVASCULAR DISEASES (I60-I69)

Included: with mention of hypertension (conditions specified in the headings I10 and I15. -)
If necessary, indicate the presence of hypertension use an additional code.
Excluded: transient cerebral ischemic attacks and related syndromes ( G45. -)
traumatic intracranial hemorrhage ( S06. -)
vascular dementia ( F01. -)

I60 Subarachnoid hemorrhage

Includes: ruptured cerebral aneurysm
Excluded: consequences of subarachnoid hemorrhage ( I69.0)
I60.0 Subarachnoid hemorrhage from the carotid sinus and bifurcation
I60.1 Subarachnoid hemorrhage from the middle cerebral artery
I60.2 Subarachnoid hemorrhage from the anterior communicating artery
I60.3 Subarachnoid hemorrhage from the posterior communicating artery
I60.4 Subarachnoid hemorrhage from the basilar artery
I60.5 Subarachnoid hemorrhage from the vertebral artery
I60.6 Subarachnoid hemorrhage from other intracranial arteries
Multiple lesions of the intracranial arteries
I60.7 Subarachnoid hemorrhage from intracranial artery, unspecified
Ruptured (congenital) berry-like brain aneurysm NOS
Subarachnoid hemorrhage from:
cerebral) artery NOS
connecting)
I60.8 Other subarachnoid hemorrhage
Meningeal hemorrhage. Rupture of cerebral arteriovenous defects
I60.9 Subarachnoid hemorrhage, unspecified. Ruptured (congenital) cerebral aneurysm NOS

I61 Intracerebral hemorrhage

Excludes: consequences of cerebral hemorrhage ( I69.1)

I61.0 Intracerebral hemorrhage in the hemisphere is subcortical. Deep intracerebral hemorrhage
I61.1 Intracerebral hemorrhage in the cortical hemisphere
Cerebral lobar hemorrhage. Shallow intracerebral hemorrhage
I61.2 Intracerebral hemorrhage, unspecified
I61.3 Intracerebral hemorrhage in the brainstem
I61.4 Intracerebral hemorrhage in the cerebellum
I61.5 Intracerebral hemorrhage, intraventricular
I61.6 Intracerebral hemorrhage of multiple localization
I61.8 Other intracerebral hemorrhage
I61.9 Intracerebral hemorrhage, unspecified

I62 Other nontraumatic intracranial hemorrhage

Excluded: consequences of intracranial hemorrhage ( I69.2)

I62.0 Subdural hemorrhage (acute) (nontraumatic)
I62.1 Non-traumatic extradural hemorrhage. Non-traumatic epidural hemorrhage
I62.9 Intracranial hemorrhage (nontraumatic), unspecified

I63 Brain infarction

Includes: occlusion and stenosis of cerebral and precerebral
arteries that cause cerebral infarction
Excluded: complications after cerebral infarction ( I69.3)

I63.0 Cerebral infarction caused by thrombosis of the precerebral arteries
I63.1 Cerebral infarction caused by embolism of the precerebral arteries
I63.2 Cerebral infarction due to unspecified blockage or stenosis of the precerebral arteries
I63.3 Cerebral infarction caused by thrombosis of cerebral arteries
I63.4 Cerebral infarction caused by cerebral artery embolism
I63.5 Cerebral infarction due to unspecified blockage or stenosis of cerebral arteries
I63.6{!LANG-b4b6bb8251ce0ddbe3704ff002749fd7!}
{!LANG-67223f0f4cd67bf2c1d5e370c80b0d04!}{!LANG-f5345001c3acd021ae04c42142c03694!}
{!LANG-fb904f9749d2897c3ecf770feeec5a89!}{!LANG-caf1b9973e08cd87315cc9b4ad7123e5!}

{!LANG-6e071597ce7ac7caee236d484265ed1a!}

{!LANG-8559049119aca5abc16d53ae0073558a!}
{!LANG-e79a139e4ca1991bdd033d92dad12da5!} {!LANG-bc6c31ffaaec5760f7483b0d9555afbc!})

{!LANG-b61705423b7ccac5111f5df57ee6dcb9!}

{!LANG-1c104d15807b18d829d0327f7a409667!}
{!LANG-7540e9b039c71dda6b26fd4b0ff8b77a!}
{!LANG-6c9486623554a84ccbe75a0f73fdf411!}
{!LANG-970e7e4bc38dbd17f263cd584aa8a0e9!}
{!LANG-e8260dddbf2e663cd6561decd24b7ab1!}
{!LANG-2c523556a516bea1258991e888bbad74!}. -)

{!LANG-3bc13fea9aa2beb77a5a3d919509ac8a!}{!LANG-54daace06e7ec31dee72faf152ce6a9a!}
{!LANG-5e1a9f2d788ddf1c9c4e82c29c618487!}{!LANG-77f52a62976fde894c3c2d375dea7f96!}
{!LANG-513abce1d0c6062f97347640622df9d6!}{!LANG-5a499aca13b8886033cca828062cfb3c!}
{!LANG-ec135a804bc9917c3bfa9876e53d67a3!}{!LANG-7814133de29608c7d057049e809d6000!}
{!LANG-bb0156001dd17a02bb4669fc36098c40!}{!LANG-86055113555549cc4311e8fb4070c2b1!}
{!LANG-9573a312a8b46b52723a4053b5370270!}{!LANG-a9cae69c55bd9f57eba5f894a787737a!}

{!LANG-c6bc1c5210de2761c6b253fb33d23465!}

{!LANG-e68e2dc84e4d6543bba24a4d6d8fcd9a!}
{!LANG-a243e42703d7ee4807a27d2766843ab5!}
{!LANG-6b75285e86ef906ffee8c87017f0dceb!}
{!LANG-4665e1422364fbe9ba929d8fc30d55a2!}
{!LANG-e8260dddbf2e663cd6561decd24b7ab1!}
{!LANG-10e9baa13cc774b5f2f5b04baebceb33!} {!LANG-2c523556a516bea1258991e888bbad74!}. -)

{!LANG-deef2dfa98b9f07b202dbea3e2562fec!}{!LANG-6fa095839aecd28a83cb1539a21f1812!}
{!LANG-ce60f3fc96551920c17a4e105b5c6c8c!}{!LANG-df62ba743ce3de2bf8503b05e51a510b!}
{!LANG-47fea7be41589527710d38f2066d394a!}{!LANG-e7efd736c78f612ba283ecb17d5ce12f!}
{!LANG-e4bba0471fd1b08952710c5f373c2f79!}{!LANG-7ba90acbb09ee5fc8e2eeb14d8f7d743!}
{!LANG-8de29b921929c8e92d4f34b6003f73b9!}{!LANG-7613824dd3f94b3aed951525921c2e44!}
{!LANG-4d0f78613170759a111fe3668a909269!}{!LANG-358d61ac44d61ebe9253c4f2eb690fc5!}
{!LANG-b34bdb01fbf378c7ca3f8bf97abb4e3d!}{!LANG-50e6a8141cf64105c805d8be83f339d4!}

{!LANG-de0da7248a568ac9c466d3166eac936c!}

{!LANG-1863c46063e5316fec38a8226cd22077!} {!LANG-b28749a6e63db603ac7f1ba904e0cd79!})

{!LANG-47a7065c92683628f7f925aa1e654108!}{!LANG-22c69e270eb45239c58b039a7bf87a9e!}
{!LANG-07574600ebe920f7bdc279f0ef6556d0!} I60.7)
{!LANG-6f8ba4eafa783b5df29b2ec32ec74ded!}{!LANG-176cc3da9260d6cda8b6a06f1ccebeaa!}
{!LANG-a8a90a2097884cea8d781dff6de9c138!}
{!LANG-363f7818691f4ef88b5a72868cc03b0f!}
{!LANG-de1c5b2b734c587e0bd845152fc1b035!}
{!LANG-b71171974028773fea01becac7c9cc2d!} {!LANG-aa05dda48e18ec0b7bb7d56f713e81a1!}. -)
{!LANG-bb0ec41973b5df467c8e16ff829f8749!} I60.9)
{!LANG-a2bead4d4ba7e6fa97af4b5cf3e74d66!}{!LANG-75fbefdf6bcf3c6784ed83c14ccc25ca!}
{!LANG-ba85ed34ce2d0df88a23eecae57a030f!}{!LANG-d1b0bc39964130a323aaead0a43f3dfb!}
{!LANG-e66f8a489c754cf9a247ae655f041317!} {!LANG-6cc751afd3987e450f9b6eadb4d7511b!})
{!LANG-30edbcb0861bf567b0093314febe8384!}{!LANG-7973008fafa9df8a6ed1cc8d76f9ddcc!}
{!LANG-b6ccded2bf06a829f9332f94ad7fc750!}{!LANG-f965894537589680dfdc55626dd016fa!}
{!LANG-bf96b3a3f4844ca4243e90eb30d3c2ca!}{!LANG-f129087d2ca8b6d40f1606b0a97605b7!}
{!LANG-fd0fb55625fbfa5542053ea3c8533836!}
{!LANG-2c6097994d1b1d6252dcfea4fbf799f4!}
{!LANG-efb2f4840a0d116ad040221b220697f2!}
{!LANG-4dcb3387509429dade1b8b7278b829fe!} I63.6)
{!LANG-b76de713e3c53ccd1c7c22abd6c82d2e!}{!LANG-ba969e6c82a7ab35de1bcab24bf2b8a3!}
{!LANG-c26c9a1a4ce2c717f768d1d044343a28!}
{!LANG-290c07846ca30bd1a587a433f1b77106!}{!LANG-b7936500a56e943b22f450a6744a39b5!}
{!LANG-d2acdaee155897434ed4f533e9ff879b!}
{!LANG-b3a799fabc275dec8f221a9083c08535!}{!LANG-9dc147b07c56d0f7417be25e34158695!}

{!LANG-b203a16b06d0592ffd21e479aa11535b!}

{!LANG-fdd0f2d1531b6d1451c0a88b16602f12!}

{!LANG-fc2d0377a0aaab3a071c520c23ed902e!}
{!LANG-572af7a3abfda2b510a13ca5df48029e!} I60-{!LANG-d7ce919a0883eb4d8d2858ca196eeabd!}{!LANG-a78e54ec93b0957c48f4290694188bf3!}
{!LANG-9af9c1c106fd86efc8de515e152cac4d!}

I69.0{!LANG-144a90508678f843fe9d54b38511da80!}
I69.1{!LANG-6b6e77872637d42c34892310b9e1f78a!}
I69.2{!LANG-df657706d667b01b9f5381319bed8b9b!}
I69.3{!LANG-fa74bf9924a96ae9f51be55d12edf756!}
{!LANG-bc6c31ffaaec5760f7483b0d9555afbc!}{!LANG-efbbd101724c99623f0db283b0582b0c!}
{!LANG-b28749a6e63db603ac7f1ba904e0cd79!}{!LANG-61f4ff0965be63976590eeb81cecbfae!}

{!LANG-bdb16a5748f823da7bea06baa9cfa524!}

{!LANG-63dd69a4ae20d56e21e4a68c804daf86!}

{!LANG-658fc17e066f2325cf89d55077fa06e0!}
{!LANG-c3e90bcd5bc7184729d719ffb7b972fa!}
{!LANG-4e9f3ae680248c60bddb7e29dd0f30ca!}
{!LANG-90d3214e8335e7e004e07a9cffe48aad!}
{!LANG-8fbd2495775022ae6b51896aee4c3546!}
{!LANG-de65a85a0d3cfb020394f161b03eeae1!}
{!LANG-ffa7cfd8acaf6cb9cb622b202785574e!}
{!LANG-1f2bc86f9be05e1ffec1d1cadc08cc84!}
{!LANG-b1ffbbebe62851adc3a5c52a0feb33bf!}
{!LANG-ca795d6be062243cc710d1972d133718!}
{!LANG-f7bce98e55f758a6976e9df7a2a6368f!}
{!LANG-38790ce863a2c343d3459a17c6e5c352!}
{!LANG-4676c279598c68f4ee27f449377cd2e0!} {!LANG-a2bead4d4ba7e6fa97af4b5cf3e74d66!})
{!LANG-86d22deb758ae09d0cdd452fef7e655b!} I25.1)
{!LANG-1e70fd0774183a208192fe36269a9f20!} {!LANG-46635f564536b80db807c0e37de80629!})
{!LANG-b19dcdc8b60613748057d5dfa10d6f53!} I27.0)

{!LANG-7db849bb27e87ecd1eef7d039d5b02f5!}{!LANG-5af6684d704aad3a40be3e2125367962!}
{!LANG-75280417d8e66fc373a6ef9cbe83025a!}{!LANG-04a8f1d9b70c661093a0699e1cad34a1!}
{!LANG-b164e2b7f6a67209f102fdc8c54d75b5!} I12. -)
{!LANG-8a7550b335d946d72150c0bfe293376e!}{!LANG-b45e6c9930343f843e3b8769244abedd!}
{!LANG-3f9e6a8ce8dbdd568d68c828719b57d0!}
{!LANG-099c8d3344e893aa8ad4c0b116681e7e!}{!LANG-8124d8c8276c10636420850978fc6695!}
{!LANG-d192109bbc4cba3ae96fa4705511ebd5!}{!LANG-770eac563e4fee8c9512a6bbccb56d33!}

{!LANG-9994eff90beee565d0a3210251876a66!}

{!LANG-66365e0969d09e88abcd5afa066de7dd!}{!LANG-6f40a9aeecc42bb5ac464af8b3d88c13!}
{!LANG-ebae915988095ba380e34c7391c66c17!}{!LANG-21c7cfdc395f39fb114b45115537ff62!}
{!LANG-5e50f6ede451bdbfb68a1a03b2999970!}{!LANG-214c2969ecece65f3d78e9f336566641!}
{!LANG-cf75c2e3c86568e0746a59ef2d2165b9!}{!LANG-4815e1aaf4e9f99ab4d214fd00626e2a!}
{!LANG-f88e7b036820c9a23315837c018fbad9!}{!LANG-1fb216a7322d4543a12c494e273f0f36!}
{!LANG-ac8aadc7f181102ca4737433c8803ef6!}{!LANG-e06f7b7e06e8c7c74a6844ccd08df9a4!}
{!LANG-2533265b0910a411f36798a057f4a27f!}{!LANG-d4b067e6961fb90232caa0977d543646!}
{!LANG-ed1eb1fe5e3d231471ec42feba9ce95b!}{!LANG-13bb87d9c3bfcf7d2cbfbdfc4e4f16aa!}
{!LANG-0907635703e8b056c2b3a71b689196bb!}{!LANG-cea6d94cc5347c5907ecf22f4b129b1f!}
{!LANG-de2d55ae6d554fc9a72c51278323cb0b!}
{!LANG-158947c7c671fd67ec64eac6b6ed7ad7!}
{!LANG-88db6edf138b1de147ddcbed0ef69fb9!}

{!LANG-9a553c216ffedd1ae3cfa4e9fd743bb3!}

{!LANG-5a1ca3a35de45e4b98ebf674e5ded6eb!}
{!LANG-b7249a8b38b899df2a3574c23de52edf!}
{!LANG-722100caf9813dc0f94b2d8ffbb0befe!} {!LANG-c56208724a89793fcade6e6addc003d6!}. -)
{!LANG-06d45b23c16b457529efd3b8e8c78924!} {!LANG-bc33a29f68500b9f1fe191538f3f0682!})
{!LANG-d8dd6d8c9f6bdd57cb8dff7ae5deb5b0!} {!LANG-11ce8e60928e3e31378729a9c9030b2d!})
{!LANG-d3d62e7da66342ce2ca7d43b79f332d3!} {!LANG-6f8ba4eafa783b5df29b2ec32ec74ded!})
{!LANG-6f6cc648913bf6eeab1d2d9ea4b1e03a!} I60. -)
{!LANG-deb346c86bb7776200ebea36941d96a7!} I25.4)
{!LANG-5ed56028f95ae14ae953a81221e6eb5e!} I25.3)
{!LANG-0b50e7f6725d571914af4e43b4bdca7b!} I28.1)
{!LANG-481c02fef187c00c3b26bc61f9cf708f!} {!LANG-513d7d477c90ccd93338bb6a99e1922f!})
{!LANG-7c2b126f2ed5713320d70cd2418de920!} {!LANG-11ce8e60928e3e31378729a9c9030b2d!})

{!LANG-14fce003a8902588deaf46a8eab7e118!}{!LANG-8945899f89718e35910eb37ee64a493a!}
{!LANG-ed341c047021f3c5dcce6e4313860b1b!}{!LANG-7bd08b4981480a0e9974f5c3617f88d4!}
{!LANG-52cfdc24791e19967bfe51d01ad08a92!}{!LANG-88d67fe84f07d4557abe6b580cffb040!}
{!LANG-ca0a66d8104e0c2a3857a78a56eae1c1!}{!LANG-247850b81b84616d8e641a769fe47124!}
{!LANG-53bef50484eb0ba3cac333fd53b6bce8!}{!LANG-4a996b34b926a2a30af8024550e84d63!}
{!LANG-729ddee25d8c89e13c4b9bbe5d026718!}{!LANG-506c9ff6d343dca2ee1e6766d282dfc5!}
{!LANG-367d6c0e65d71e24142518d2f08b0f51!}{!LANG-8ce46e71879c99947235f6125324c445!}

{!LANG-6ed9f58e22d751910951a5c7c2437e4b!}

{!LANG-61616b620610bc6883b156098fab01ca!} {!LANG-7ac45c4e9113726d933862c74f34d19d!})
{!LANG-c4c6ef9901038d724d2b01e52ddd3150!} {!LANG-3c0e8992c5db4cefae0e1e0a83f532f2!}-{!LANG-ad147daa43ab36eee045653b74f86e6e!})
{!LANG-15977b2667ac5dd9b1779e53e1b785a5!} {!LANG-2af0c24963ce11a344cabab8baf051aa!})
{!LANG-c9fe9d17bee4a7eb20a1aee7d06a375b!} {!LANG-0806702ee90d02d037fa2b357fe52138!})

{!LANG-746f94058f70ebd1ebc9d313831237ba!}{!LANG-a0d5ced475b67fc4b0d8a04232d774a5!}
{!LANG-7ac8ccbe29ee8c5050d7e9cdc94ccfe5!}
disease
{!LANG-96126c2dd0201cd49e40f90f4aed5e91!}
{!LANG-3fe889964c836b63f876af2d944d60b5!}
{!LANG-81ca83e95cd1ac58b941a0f2f8525c82!}{!LANG-7b79278e634c6158e2e48510b9dd4ed2!}
{!LANG-00a70a44e39ea84f8faa0a3ec899ebbe!}{!LANG-e5d8fe173399ae31970ecaea60dd9f6a!}
{!LANG-55be9bd525ce6c6b955a9c3963c68971!}
{!LANG-93f59109a29e7a6f06beb239587f58eb!}
{!LANG-9075fd4e20f5048c2debb05ebea41827!}
{!LANG-9c2009419ce8ec082d120838d40eb617!}
{!LANG-5e3eff1775e86f23b115ac42b5d50f95!}{!LANG-73b39e46d16921a43d8285e07a44157a!}

{!LANG-4602f09d9edec84d0d9e7d3f1d8ac1fe!}

{!LANG-20171191d9e70f6a53a6c713c66e8d0c!}
{!LANG-48aa0aa4fc3fe27c3a8ecc959f778274!}
{!LANG-9fb4930874f247138c20c68618f11fe3!}
{!LANG-39d07e0c15a378e1b283791edd59e2d7!}
{!LANG-f7188df27d5e516e6bf6aab09603e1c8!}
{!LANG-41e630adc7557ee1ce3d07d862ac6d05!}
{!LANG-5fbc0da94b5579a817ec05c1b8f42219!}
{!LANG-4bb09e71f0fb21441adec9a49c11b488!} I63.0 -I63.2 , I65.1 )
{!LANG-6f3542ad79d12e4e6007066f5aa8e979!} I63.0 -I63.2 , I65.2 )
{!LANG-67bcbe9545d363224f82a341f89f4d81!} I63.3 -I63.5 , I66.9 )
{!LANG-881bcc447c2be325ac7036b0326b62fb!} I21 -I25 )
{!LANG-178d950add99260b9afa7470a3799895!} {!LANG-fb0929ec440dcbadbffba813069b461a!})
{!LANG-327994a4eea74417a0b9567b4ca362a1!} I63.0-I63.2, {!LANG-9573a312a8b46b52723a4053b5370270!})
{!LANG-bc46294855b0ac0b0e7b957c3759b820!} I26. -)
{!LANG-9099fac1198c5a6ab1ebe92f4274052c!} {!LANG-77da991ef613dbaed45fcfa73024c394!})
{!LANG-2d227bc4291e0467e3cbf4d6e1161a59!} {!LANG-0432321659ffc20d61e17f75121ac223!}. -)
{!LANG-54184c5fd70833495ded9098eb76233c!} I63.0-I63.2, {!LANG-3bc13fea9aa2beb77a5a3d919509ac8a!})
{!LANG-4be8e4551a6fc22e4992f819b08bf0df!}
abortion, ectopic or molar pregnancy ( O00 -O07 , O08.2 )
{!LANG-84adf54012718a50dae9424e9dcfea01!} O88. -)

{!LANG-471bb3fafdc8f07e8c722ef1e1fc2492!}{!LANG-aafa0a597e3791e6cc434067cbaedab8!}

{!LANG-1cf1d43f781d9acba7527ebdef268b57!}{!LANG-f5f16d590547b7916bba258be1203dc1!}
{!LANG-acee85a517bce71d7268a284b8edfb99!}{!LANG-c46a427e8a2881d4912ecd6a2590635b!}
{!LANG-b064ba3ac189b5d4864d29838c846922!}{!LANG-12df94ccecb5385a9a6ad8caa26d6ab9!}
{!LANG-530dbde7b1933e1619c9e53e2edcf860!}{!LANG-5b3039d7a91cd7f3cc51720eae216a04!}
{!LANG-5f809acfaf749532c8225f69e49489e0!}{!LANG-dcdea64e2bd817d1cc4d3224f73c377b!}
{!LANG-2a9f32aad46dad3db11ca8533f763860!}{!LANG-53ffa5b5c54a98c486e624324cbe6fdd!}
{!LANG-1de653c0b115d85bd934a9d67c0eaca9!}{!LANG-031e3d35d10c008d062db6369f8a9000!}

{!LANG-a0103e4a28a2a0f607044896a7c476de!}

{!LANG-bc91adbc4024b2325fb9ca9ea185d884!} {!LANG-2d3ba1a92710a7c22d0a665391a94d3c!}-{!LANG-4543007e47382b27f33330975a20fd36!})
{!LANG-9090b0b5fd39d0f84825cb76e185a583!} {!LANG-599835f201e440b2e8ddf833e03a5614!})

{!LANG-d5d3cf1929222b88c3207d0f9a71d517!} I28. -)

{!LANG-11ce8e60928e3e31378729a9c9030b2d!}{!LANG-01572c3877244559f4ad417cedfebe3e!}
{!LANG-5eab056e3789c866fccc594f7f2729aa!}
{!LANG-235cfb4400a62f8dcb49ad506b469d4d!} {!LANG-bc33a29f68500b9f1fe191538f3f0682!})
{!LANG-e95a68a0ac515e941af6ed7a84aa1795!} {!LANG-6f8ba4eafa783b5df29b2ec32ec74ded!})
{!LANG-1747b66a44c514fb26e22741bc70fd27!} I25.4)
{!LANG-b2468e121869f21110b39908af83f29c!}
{!LANG-fec04e42aa498a3a946587523ad16fa6!}{!LANG-2a25a7283701e440fba63570097a3081!}
{!LANG-c93e2348ca7dd4fa90f161dead3bed3c!}{!LANG-ad4777b22d06fa750b8ff805d88c684d!}
{!LANG-131ce39fbf0a6bdb37ebfdfd067c51e0!}
{!LANG-cae01c04c0364e0cbf32dda0f68dc13e!}
{!LANG-51938677ba22cfb86740550e02315f29!}
{!LANG-3f5802af8c68e604eb81d1c2cf07ca7f!}
{!LANG-750ea09c2e23470f2658ebd9f6420eea!}{!LANG-de3b93e6ee47cd08f4485949c5928356!}
{!LANG-2fc00753e077d97b5df703f5667691bf!}{!LANG-5e6ebd835281c79f8a58f98fd536b119!}
{!LANG-e8d001678b82b66b8fe397234d543f2d!}{!LANG-5ec37d374ecfa14aff618e0448e250f7!}
{!LANG-2619c67ac9a72101aeef5d9ae1f7196a!}{!LANG-a72e2cd7385e9782adbb4575d2281863!}
{!LANG-dcde9a5985054f1c904578a59b59645c!}
{!LANG-16dbac47c8e6bb9093e55dcf27536fb5!} {!LANG-216b6cd4b7e941b0fae27d268757f496!})
{!LANG-0aa71423c5daab54f3086c095c538843!} {!LANG-b76de713e3c53ccd1c7c22abd6c82d2e!})
{!LANG-9f77ffeb6903a2f35c38235ee11f83fc!} I25.8)
{!LANG-7495fef39104bb2440e23b7f165b7762!} I70. -)
{!LANG-9a0823969616db7559b5927a8d2328e2!} {!LANG-fa60172864086f5f75a914cc1c93b801!}-{!LANG-63f4a7b1a68fae515a7afd3cbd95828a!})
{!LANG-c1526c452456b6c25fee8d78776c50ab!} I70. -)
{!LANG-17852ff65809cbdc2b9942274b03bc55!} I70. -)
{!LANG-3ee4a3a7815819da17a6b5d7d3768a73!}{!LANG-551e18fa332c8aa47ed4f2d2b5fe5634!}
{!LANG-5ca10286aa75684f42931469023945e0!}{!LANG-8322b91685a13092dd02b5269a4145f0!}

{!LANG-bc13cc118fb62a6a4eed34b5650064be!}

{!LANG-03948b3a23fca27bd833592fbec6e14c!}{!LANG-8c9a223446a46ae7b6484892f2e51d68!}
{!LANG-3282f4a2693a1a8f2de818c04754edd5!}{!LANG-12fde4e38b8523ef6a00244773f0fcd7!}
{!LANG-ca97b50708e526160652afd35ec0b495!}
{!LANG-5869d50fe022b9bc1edb8a069136da5a!}
{!LANG-334ad03cfddfa5353db4be6a1d045c7b!}
{!LANG-b935cb6ae03268a6d21419dd78b63f3b!}
{!LANG-f290d60053146f337446c590c9b81345!}
NOS ( {!LANG-87795b32248f15ca3d1ed4d00dd01347!}. -)
{!LANG-fa45c2514f7ef66a74939c251cb27a2b!} {!LANG-87795b32248f15ca3d1ed4d00dd01347!}. -)
{!LANG-f36807d56f3ce3fa3f0c499023b5b60f!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-5f243209203efc122ed5fa408ee3537d!} {!LANG-87795b32248f15ca3d1ed4d00dd01347!}. -)
{!LANG-224aff1b94e145fb65b083d085740b59!} {!LANG-87795b32248f15ca3d1ed4d00dd01347!}. -)
{!LANG-93d552de6d936f975e2a1e5a758499aa!} {!LANG-87795b32248f15ca3d1ed4d00dd01347!}. -)
{!LANG-ce70e3019348e17dfcc0464de3e8b458!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-6928d488f7a8ac6a6ab276406eeea786!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-c8a90b563bb6e7293f497c786b83a171!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-cb5718ca8944aefefe0574e30d1a2377!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-1b379c2e78c2f9ffb7e9827ae7ede6f3!} {!LANG-23ef81bfe5548cd26ddb8f2f1c06a79e!})
{!LANG-c342614d76342f666cd29acb96d6bfab!}{!LANG-0711575d34e1c7553b1721f8943e060c!}
{!LANG-5d0e818467491537f17884aa4243aeed!}{!LANG-b6a6a6412bd24260c037404018df9c17!}

{!LANG-74acabf2109a81df253f58ea67e776af!}

{!LANG-2e69868ff1cfabe89a8e5f5b12ec3f82!}{!LANG-624f7d94a4b97a6e5e2618a90798dd48!}
{!LANG-83e2ffb0721d7be956f9829c4fd18cb3!} A52.0+)
{!LANG-309b0dbea70e1980915a51d7a80f07af!}{!LANG-c3dc3c00cda191f57ae923952f3be9ef!} A52.0+)
{!LANG-a43dfbae1b86ed268980d65f3fcf2531!}{!LANG-e5cad4d3f5849b9eb7f70872b04d004e!}
{!LANG-57002905c183ead6892b3fe27eefbb04!} {!LANG-eb5b4433a2d2cda0e2af53264f91db9b!}-{!LANG-94b197a40d10431caf6d24a3dcec2f8d!}{!LANG-826d18f01576ece4f8be258746b66591!}
{!LANG-af869688a2dd45c5fa72fbde82a9debb!}{!LANG-a1e045df323cde76e05e3ea14f89679e!}

{!LANG-522f843356853f3f737d88118d031273!}
{!LANG-9ebcdf216e85ee092ab3e221cbb6b7eb!}

{!LANG-cf0723ec190006f6cd36661a891d413c!}

{!LANG-a409e7d586e8bf77e272ef7dfcf0bc1d!}
{!LANG-a6c8280b5781a5a3e0b59a6c0cee97e6!}
{!LANG-07a11a1cfa31db70bfababf79bf14445!}
{!LANG-9ad66c247a807079491dc741c3eeeeec!}
{!LANG-f7454453d4b22a8699bb1118018c80c1!}
{!LANG-4be8e4551a6fc22e4992f819b08bf0df!}
abortion, ectopic or molar pregnancy ( O00 -O07 , O08.7 )
{!LANG-84adf54012718a50dae9424e9dcfea01!} {!LANG-0aed3a773f917661fa2c73987a13fcfc!}. — , {!LANG-f3a69ce505594e688fc34027830576e4!}. -)
{!LANG-fe273f6cb4bbe34645d6205ae442b525!} {!LANG-518ec4b7441201473b7260715b5cce5d!})
{!LANG-95400245784018ff9b5ed4189f3de541!} {!LANG-bf96b3a3f4844ca4243e90eb30d3c2ca!})
{!LANG-e65e90ea8b16996fed0ecd47b6381f77!} {!LANG-9a50166aa8577dea03663d32560c9f93!})
{!LANG-80c2f4e953f72810303494dbf87996b1!} {!LANG-930ba911c3dfa4a4753e819214a06083!})
{!LANG-2f3ec73575000a124c7c93c2d04c20dd!} {!LANG-60fc6a843bb5f2f11c9c0a5a4d83c571!})
{!LANG-3568f0f137af6d37ad5251b04a06c4fc!} {!LANG-4619b2043eb8e9c43eea65921cae9ad9!})
{!LANG-96aac568acb670fb493f492fa1a5e51d!}

{!LANG-3ecb134c1295f42155d5c78f321fb78b!}{!LANG-f99336f918e4fdc7821c625dd8a50a3a!}
{!LANG-c778895862e231c9e40bd45963d1e2ce!}{!LANG-ca96c65c66a2d927d8f21efd692acd6c!}
{!LANG-a55d9db49ad612474737215bb0b05cfb!}{!LANG-f51ba2bd3b886028ab94a8abe59c0d6b!}
{!LANG-9e93ab441bedd81dbc792589b931e74f!}{!LANG-27df74c838ad0e85b9688fa7497851bc!}
{!LANG-9e780e2c1360dd2465cc6e0a8b2fd597!}{!LANG-46bd2a8009bce097a45748837ea0997f!}
{!LANG-be56d0e734a217bc3feaba6f5fe22490!}{!LANG-ffeec3551de02a5c675cf78267c46379!}

{!LANG-eacaa5d2b1e8178f7a9d862f53f87e6c!}

{!LANG-5af7cf2531f48a2f6897002e1f1b3ac2!}
{!LANG-6180b1a7c654803d663620eba1ae88c7!} {!LANG-930ba911c3dfa4a4753e819214a06083!})

{!LANG-bac88fed1e90192ca1abcae360b566ee!}{!LANG-1f02688fea6fd39b065b1dbb1b1ed442!}

{!LANG-beb0812d482e935ab8c922ae1ada1e74!}
{!LANG-eccb7854fdee6cda058dccb78ea9923e!} I63.6 , I67.6 )
{!LANG-22ebf49690564903ff6874a8731d6017!} I21 -I25 )
{!LANG-a13865851b5e5acd48ed80b95a1bbc56!} {!LANG-518ec4b7441201473b7260715b5cce5d!})
{!LANG-9ca50c042384e8b896249904105b9bd9!} {!LANG-bf96b3a3f4844ca4243e90eb30d3c2ca!})
{!LANG-3ad0f927766125006d1d7afcaa1a6a5a!} {!LANG-9a50166aa8577dea03663d32560c9f93!})
{!LANG-0c8c1ec7f81917dab9bd546fcfe4be42!} I80. -)
{!LANG-3df330ed6011beccf69dba2ea60effbd!} {!LANG-fb0929ec440dcbadbffba813069b461a!})
{!LANG-6142c361b6347973e7215f59a5953bd6!} {!LANG-13eb5e563f8b39a7e4099921e4fa1187!})
{!LANG-a3bb03c8a28f00fef34d90dc6f220134!} I26. -)
{!LANG-4be8e4551a6fc22e4992f819b08bf0df!}
abortion, ectopic or molar pregnancy ( O00 -O07 , O08.8 )
{!LANG-84adf54012718a50dae9424e9dcfea01!} {!LANG-0aed3a773f917661fa2c73987a13fcfc!}. — , {!LANG-f3a69ce505594e688fc34027830576e4!}. -)

{!LANG-7fcf8351793dba3f4c94008fa2bb0344!}{!LANG-d53499d670f455818c2c971efe2c73c7!}
{!LANG-4619b2043eb8e9c43eea65921cae9ad9!}{!LANG-b3e3462dae9a2650ff18bc574db03022!}
{!LANG-530bb4daed78b130aa26ae7cd7cc7e7e!}{!LANG-8fd16f41b59f04d3226c94b7f7ad20e3!}
{!LANG-036d332d6b6f58c1aa99ca790795aa33!}{!LANG-0686776aac0454dda5f7b04ea7fce5d7!}
{!LANG-0038fabace63d735e6141f33f53a8d5d!}{!LANG-8e0d2b87d9f8851ff98358718e8620c5!}
{!LANG-b4a3d408f43747048a153e2241a08bc7!}{!LANG-5fc7dd4036262aeef3c35119d813435b!}

{!LANG-52b296f07b5d2935052caf27b3b11367!}

{!LANG-8c23e9d57d9c5bb288079743b249c60d!}
pregnancy ( {!LANG-8d66de6c2b84f5f2ff9b909607f4993f!})
postpartum period ( {!LANG-9efe8280780cd1495701c1869a16897f!})

{!LANG-a7b1b18edf274c284354fbf36f9baf6d!}{!LANG-a00533e3a9a42efcba38e446e0c7dfde!}
{!LANG-7aca4401b6dde068d34bedb2d58873a7!}{!LANG-499c0d1f659791f6750ce30ce523883d!}
{!LANG-e31809ee9704ea0188e86ff6ac2c52a2!}
{!LANG-64e66844bea6416798be3699478e658c!}{!LANG-58c89b4f71b8047f0e9eaac768905709!}
{!LANG-a646131a9078ae0b749bd1180c85d438!} {!LANG-7aca4401b6dde068d34bedb2d58873a7!}{!LANG-b954755b414e0eb9ded571c857b77129!}
{!LANG-61538955e17ad230121f544da27a4e11!}
{!LANG-f45ab00a161d4a9a355bda109c74c834!}{!LANG-6a2b04370ada16e2fbd97d55d8aee3a7!}
{!LANG-a646131a9078ae0b749bd1180c85d438!} {!LANG-7aca4401b6dde068d34bedb2d58873a7!}{!LANG-9389745fb21bd7aed6777f395e30cf2e!}
{!LANG-7aca4401b6dde068d34bedb2d58873a7!}{!LANG-22d08a8c6d0792390d6868fe7750bd36!}
{!LANG-f4c708a2882bc9892d49b8db3c12b655!}
{!LANG-40583b304f357e28a14eb3f0504210e8!}

{!LANG-91fea9caebd93a6f4e9ea42a1a0ea31a!}

{!LANG-130ea6f1847ea22ae4a4226c63cc8146!}
{!LANG-0ce86830868e4e6f661fbbb6298ff35b!}
{!LANG-e8e6ff42a26ed48655f226d79f7573e9!}
{!LANG-08976ed0adcb12384340816e5ec3df61!} {!LANG-1afef17e373ebd400a62528b9f313e1b!})
pregnancy ( {!LANG-7ee6e791c96358a9faf3047841caa684!})

{!LANG-0455ea7f12344c60f8f8e4f88eb125b7!}{!LANG-27ad46bdcc28c747c552acff7ba6338e!}
{!LANG-52f8547298f7ae31f733fca00af901bf!}{!LANG-d6cf9df647c56b37f564fa8988a2431a!}
{!LANG-b2f399b566d444c157cd3de5f2fd0e4e!}
{!LANG-6dd416f86efc4cd6cec355580a1003db!}
{!LANG-c6816777ce81ade9108767791a616b2e!}
{!LANG-786760405b5413891413291e53eef757!}
{!LANG-de31cc746b42c3fb25ce80cc89a0267e!}
{!LANG-9027ae0ef2cadfc21314804d2d10dd17!}{!LANG-235187e221d7b18b6f5a718eed5ee055!}
{!LANG-12b5449db43dc1b7591e8bad91a11bd2!}{!LANG-014047364fb6e4f9ef32af580a256566!}
{!LANG-89de6082664f0f2c85d12d67d8da4162!}{!LANG-2d23503474301da1b1bb843ee8ad0222!}
{!LANG-e6e16ee5675c30e5ec055bc467f52fc1!}
{!LANG-6dd416f86efc4cd6cec355580a1003db!}
{!LANG-c6816777ce81ade9108767791a616b2e!}
{!LANG-786760405b5413891413291e53eef757!}
{!LANG-de31cc746b42c3fb25ce80cc89a0267e!}
{!LANG-d51c0dbbebf8e3bed572baede7dc1344!}{!LANG-f98e64d57b1ec5d074f0a94922907509!}
{!LANG-95dbb67fbe430b692f01d35f4f37ac32!}{!LANG-325c1da948debeebf985833f4cafa81c!}
{!LANG-d69dfe89bd8d1942913c770ee5c0ffeb!}{!LANG-741069f48ae6fc3ede107b7d0dfffcc3!}
{!LANG-a0a1beef2851d14bf84d5236083b9753!}{!LANG-1a35e4228c4ccd74d033771662c815c9!}
{!LANG-8c07755a148d4e7347249aa65706559c!}
{!LANG-6dd416f86efc4cd6cec355580a1003db!}
{!LANG-c6816777ce81ade9108767791a616b2e!}
{!LANG-786760405b5413891413291e53eef757!}
{!LANG-de31cc746b42c3fb25ce80cc89a0267e!}
{!LANG-129222b8f2c90083171eab6c5e582415!}{!LANG-7b7cc6793a14b369107b92a9b7f3e1be!}

{!LANG-dd8fbc5a6d425018ea6748e192583e59!}

{!LANG-15b0bd9bd208e87aca40170873b0542f!}{!LANG-ad3e50722436f5b5d4ac5c504544e463!}
{!LANG-0d240d101f8c5334ebe6d78a25223975!}{!LANG-7f2067e2b3c8020a12f8336509ab3abd!}

{!LANG-7bfa8c17162b5da0d1ad2ac21f30b75f!}

{!LANG-c9696fa8436e6d047650efa63d2a9a31!} {!LANG-513d7d477c90ccd93338bb6a99e1922f!})
{!LANG-cd3005023803896a625bc48ab411f132!} {!LANG-7aca4401b6dde068d34bedb2d58873a7!})

{!LANG-b67803a792863d7d2c2506a63ed2014a!}{!LANG-76c7d23ed7912d16e3f36ddae08db68e!}
{!LANG-08af95e9d8f818b91949a66632e72107!}{!LANG-8a957d2c4728bf0f1fdd2700cbc95553!}
{!LANG-c32e6db68a1c0990f74bcc6a6f80c3c9!}{!LANG-aba6af4629b98e829ef9dcf83c62a8ef!}
{!LANG-91b705493994a8d3cff631f8b7d565d5!}{!LANG-b97c5604639e0b792036a1ff4ffb7487!}
{!LANG-2f4b7c51ba63588544cca0bbf29e2a41!}
{!LANG-ebd0a23753451c003b6185cc71df2acd!} {!LANG-9efe8280780cd1495701c1869a16897f!})
pregnancy ( {!LANG-16ad1fba73e76324644d887992fe4c4d!})
{!LANG-e877c37e4ac8719dca129d3c4d186e44!}{!LANG-6484741fd5c6216ed343d3d833528190!}
{!LANG-7c08156a938190fe4c4980eb1b2f70fa!}{!LANG-691623ccbdcd4dbf326183dc0efb9976!}

{!LANG-33ab56cfaa8eaf5e2968f78246892ce1!}

{!LANG-60fc6a843bb5f2f11c9c0a5a4d83c571!}{!LANG-365f3f38afa4d7cfede1b29ac3518a5a!}
{!LANG-2087a0a773fef9938f52538729666b18!}{!LANG-8bc61d17d6db5f9f0b276b8d9b296771!}
{!LANG-c36e147b85b5fc61d1277428a8cf9632!} I28.8)
{!LANG-5be1c6d1b81c2c13ad51be11b4c0bbca!}{!LANG-c7234d2e26e0bab20397cb44a8df6f6f!}
{!LANG-5c0c61ce0ef7a408067960fd32dc5f44!}{!LANG-1150007452878da2da545b447354e78e!}
{!LANG-5986353ca904685a1f85acb00660ef94!}{!LANG-3fd65d2e0b0a2145593e4cb6a4c0fc5e!}

{!LANG-20339f8ac5201463ca2718ff204507dd!}

{!LANG-ef3a15d9ac99d2c54883a911237dca0a!} {!LANG-15fbc6bedb5b371d1f8b243d03d192d9!}. -)
{!LANG-47381058cd5049b75097d4811b4ceba3!}. -)
{!LANG-29687839146c41d6a84e3fdbc9db0a1a!} {!LANG-8abda7dffa1221a0375de1a65a594ead!})

{!LANG-d31c8d9160e32eaf890859625812632d!}{!LANG-88f8a5c9930d039aebea135a040f749f!}
{!LANG-af4d17622d2062d611ca8b3a5778ef3a!}{!LANG-4376a90b51cda3973e8616e98a8a012a!}
{!LANG-15dfeb6320472f7e1bc2e3e18f3c7ecd!}
{!LANG-b2ff4a27b79a06f4c7aa53f2fe6e8e18!}
{!LANG-4b86ee066a3102de3018f1b37b6fe3bd!}{!LANG-49479b1bb7520f1b13bf4acd20da8e11!}
{!LANG-75e58c02979689fbe3b713b08966c6b8!}{!LANG-8902c1bd4d80a8a989c24c25070810b9!}

{!LANG-3c36fb33811ebdc84783e685ff27a06a!}

{!LANG-116cc469f315f80a2be9d4ab06eeebef!}
{!LANG-c8de1d417f710f6343be131574bc14cf!} {!LANG-ec0ae5cccba263e19ff9ed8b439991da!}. -)
{!LANG-fced14eeb2182b3cb987cac2702fdeee!} {!LANG-cb63874daf91e318722a636b7d6c96bd!})
{!LANG-2c9014e09437e8e2407ea26c7fc6baeb!} {!LANG-47381058cd5049b75097d4811b4ceba3!}. -)
{!LANG-e7999aa6f2351e63b3b6dad09bdbd5e7!} {!LANG-3d532eb57cc5a390202105d8c417ca2b!})
{!LANG-370fc305ab6564310ef324656db2cfb7!} {!LANG-d1599b5125aba206b9dbee4113174824!})

{!LANG-ec05f1845837604407f6fad539f1931a!}{!LANG-fa95cb58382b5b75797f6081c018cb42!}
{!LANG-936e05a49c42f5b3836f543637a957d4!}{!LANG-694eb8e605f352ee2906e22c8a31597e!}
{!LANG-b7f194b8158e04e1944ef4b40e4afb01!}
NOS
{!LANG-87e1130b621b580ede68bde83416d4f6!}
{!LANG-f0c1eac9f0771ed00e60d04c7b49021e!}
{!LANG-84ac583fc3d24754bbf73608897cc83c!} {!LANG-2e88f7302c60915605d1d0b983d8dec3!}. -)
{!LANG-5a1636bc7fb59b80a1dd880af34e49f9!}{!LANG-5b99da35b9a75b6844c165d95f06ec1a!}
{!LANG-a288cec97e212ded6d4b33d730760642!}
{!LANG-b0a3cbd086cd5307df3cc4d53a7771ef!}{!LANG-475b6aa5a0d8935fa22f36f84fc202c2!}
{!LANG-877d32557a845029f911a103f8f0db3c!}

{!LANG-445fbce12b1e0732c7bf70dc20d5abb0!}

{!LANG-db9f8212df3974d3e09d7e1176b1065f!}

{!LANG-88c9201221991215ca4058dad381e5f9!} {!LANG-3567fdfb14485145fbcf5fb770f2c125!})
{!LANG-c20a77b9163376161e39e3c0df5e9fa6!} {!LANG-8ab82e63c8d8c3336b3208d9f130f7ef!})
{!LANG-8765882d50ec092dbf58242605f73ee0!}
{!LANG-fc8fa4bc0a2291a4f92842e049f92378!} {!LANG-0cd40f2536e86b927e6c3d82e7543710!})

{!LANG-af62cf7f336a6d233a58ed46fab4a9b2!}{!LANG-ec4d5f64fe21f19abf46448422487523!}
{!LANG-54604e76a96ecdca9febcfaab8af5066!}{!LANG-3c89d893851e4bad893e98053b46ca96!}
{!LANG-390d4ddae6e5275f7a09d9b9b10c3320!} {!LANG-eaf556e785870cbdec216d7ab7e144b7!})
{!LANG-88d85c6c40ff9c258b36d5b7e483ea63!}{!LANG-d8bdb1a2d506e38bfed013d3f729d034!}
{!LANG-4a5e56d1c423fe53fe91cc551be0c71c!}
{!LANG-f7b78f5ff8ba641b1ac4df32da3f9b48!}{!LANG-56f05c28432b5d83f99c5aac46166ef4!}
{!LANG-5b51566b250d359c6fdac60ba3aca85c!}{!LANG-f1425af5a7b7fae95c8505c529c1ddf8!}

{!LANG-85c57be02916c1b7b30ae96e906747c0!}

{!LANG-86563fd36dd40a5861e0ea59c5183032!} {!LANG-0862f43ef527ce3cc98ee5a25de408e9!})

I97.0{!LANG-2d10ba63d3de21aa312d0f075a93bd86!}
I97.1{!LANG-93fe460a8d8e9546b48fd4cdb368f0a0!}
{!LANG-1ff2c002518e718018a6bfee926b965c!}
{!LANG-4076c582afbf20daca5571181915b3a9!}
{!LANG-8f4c1c386ae63875fe31874b21727448!}
{!LANG-d1599b5125aba206b9dbee4113174824!}{!LANG-524fe1522b1a377ea46aa2c29071dea9!}
{!LANG-d2dfcddd6e3c85d133d0d5dea9589ba3!}
{!LANG-5ecafe4227eff3030b4674bec7dd2a24!}
{!LANG-d0ef82407313a8c47fc15d781feae88c!}
{!LANG-22d433403f7dc14e7c09efd1b6847c46!}{!LANG-0aa0f8e6fde924d2a4fd8f8a95fa9dfa!}
{!LANG-cc1accb4de88c1b460d166021cc50560!}{!LANG-15d02a3e9074f015d8d0cc7a19e83ae0!}

{!LANG-b5a5690cd52683aba9937402beb57d6f!}

{!LANG-f535c95bfae47f91768aef1868cc33b7!}
{!LANG-e0a3773ce57e92728ae909bfaa553f0b!}

{!LANG-d2889392db36ca2ec981e438c7ad7421!}

{!LANG-eb460c56af41a19abf0af01771564912!}

{!LANG-070d53f7dcd3d6ba58ea81232d52feb2!}

{!LANG-9fe20dcee570599cd285b85a04511451!}

{!LANG-d75e3d68aea139be27826218f27a5833!}

{!LANG-efdd87bab8e77fb69fad278479abdba4!}

{!LANG-abcffd298dcd046df034403548151696!}

{!LANG-149b5fcbe3d8227b262127187452a04d!}

{!LANG-32caa56be0402ad06c19f2a8b0504230!}

{!LANG-177f0f7273e2a06e22b2942fa9d4e07a!}

{!LANG-74b71cc0f9dc2444b1e41bc5397cbc81!}

{!LANG-4122ba964aae006e4458bb9d8cb10957!}

{!LANG-74aa7e1b3c85f18e87554e3318d52a9f!}

{!LANG-2dd14684006c4c43054a48120fef64a7!}

{!LANG-88b625fa64316c67c784841f1bbb389c!}

{!LANG-0d43921a4ac9e7cba887401be4c8a0c9!} {!LANG-158b655da3195ea7a6f1dc3d39f04fbf!}.

{!LANG-ddee27b4a7eb67219463a72a043529b0!}
{!LANG-326ecf733d37516170ee3410867a306a!}
{!LANG-f47ed51a51be5db57b7a8d76225ec16a!}
{!LANG-15154a6bf7550de976b8f754a80fa2ec!}
{!LANG-465159fe7b090f55fa19be3c024667c4!}
{!LANG-d4a401a5c68bb76bad48c79c2dca154d!}
{!LANG-02888070a3991c7fc4aa8da5a35cb578!}
{!LANG-facd240db778fd667694b71014251338!}

{!LANG-84c1ff7d35604edfb4225c7772b873c5!} {!LANG-3d0051bb7ea7c68509ec5b2aeec39470!}:

{!LANG-f44edb3c7b4f61fc31b7dff7ddc6051b!}
{!LANG-97c97f419d66b7ff2984651914723ad5!}
{!LANG-7269ea61289be7f1eeb178b454889da7!}
{!LANG-6ffc0df8ffa711dfe15cd45c3bf600f4!}
{!LANG-1374f480464cbcbded601a17687d56d8!}
{!LANG-6aa1e4929f5ffb80f00006e0a797b5fd!}
{!LANG-09c1563b25913eaed991bb1d10e54ac1!}
{!LANG-9ed10477126f927e20048c494f4b70f7!}
{!LANG-abf42378f1feebb58119491dc0d54f69!}

{!LANG-784feb26887af3b18e71b27b9a56c867!} {!LANG-875ed39bff92c39b0bf33fac667dc54f!}:

{!LANG-b63bd5875f10c1c1ec176f383f995c8e!}
{!LANG-920c0b9dd128a0d52cd76396a531fba6!}
{!LANG-e36e5b82c48a0aeaafb5eb18478d7895!}

{!LANG-18ff04bce0802cb7e9a13d416d8f462f!}!

{!LANG-49f0ae97a0ee977e16b94f9621a32b02!}

{!LANG-17f17a2a2adf4f60301046421c3ba923!}